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Paracrine pathway activities are being increasingly recognized as instrumental regulatory mechanisms of epithelial-stromal in-
teractions that play important roles in physiological and pathological self-renewal of stem cells and in the initiation and 
maintenance of neoplastic tumor development. Stromal-specific Hedgehog (Hh) responses and epithelial-associated Wnt 
pathway activities have been recently appreciated as important factors in stem cell self-renewal and carcinogenesis. Further-
more, Hh and Wnt pathways frequently crosstalk with each other to regulate the growth of epithelial cells in a con-
text-dependent manner. Because small molecule modulators of Hh and Wnt pathway activities are readily available, emerging 
roles of Hh-Wnt pathway crosstalk in epithelial-stromal interactions will shed light on the development of regenerative and an-
ti-cancer medicines. 
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Epithelial and stromal interactions play critical roles in em-
bryonic development, adult tissue homeostasis [1], and in-
jury-induced regeneration [2]. Deregulation of epitheli-
al-stromal interactions is often associated with diseases that 
affect epithelial cell growth, such as in tumorigenesis [1]. 
Despite progress in understanding the activities and roles of 
epithelial-stromal interactions in various tissues and diseas-
es, little has been known about the signaling pathways that 
directly regulate epithelial-stromal crosstalk. Accumulating 
evidence has highlighted the underappreciated roles of Wnt 
and Hedgehog (Hh) signaling pathways in epithelial-stromal 
interactions [3]. In this review, we focus on the recent pro-
gress in understanding the roles of Wnt and Hh pathway 
activities in epithelial-stromal interactions, the crosstalk 
between Wnt and Hh pathways during physiological tissue 
homeostasis, and carcinogenesis. We also briefly summa-
rize the recent use of Hh and Wnt pathway modulators as 
anti-cancer medicines and their potential application to tar-
get epithelial-stromal interactions in pathological condi-
tions. 
The Hh signaling pathway plays critical roles in embry-
ogenesis and adult tissue homeostasis [4,5]. The paradigm 
of how Hh signaling is normally operated in various tissues 
is that Hh ligands secreted from epithelial cells act in a 
non-cell autonomous manner to elicit supportive Hh re-
sponses in stromal cells, which ultimately feedback to affect 
epithelial cell growth [6]. This circuit involves feedback 
interactions between Hh-producing epithelial cells and 
Hh-responsive stromal cells. Because Hh signaling is one of 
the instrumental cues that regulate both embryonic devel-
opment and homeostasis of multiple adult tissues, deregula-
tion of Hh signaling is often associated with developmental 
syndromes and carcinogenesis [7,8]. During embryonic de-
velopment, loss-of-Hh pathway activity due to Sonic 
Hedgehog (SHH) or GLI2 gene mutations leads to holo-
prosencephaly and multiple pituitary hormone deficiency, 
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respectively. On the other hand, gain-of-Hh pathway activi-
ty resulting from germline mutations of Smoothened (SMO) 
and Patched (PTCH1) can cause basal cell carcinoma (BCC) 
and medulloblastoma. Although Hh signaling was initially 
reported to act cell-autonomously in the initiation and 
growth of neural and epithelial tumors such as medullo-
blastoma and BCC [9,10], accumulating evidence suggests 
that Hh signaling could also function in a paracrine manner 
in other solid tumors to regulate their growth [7], in which 
Hh-responsive cells are restricted to tumor-associated stro-
mal cells and tumor epithelial cells secrete Hh ligands. Fur-
thermore, in response to Hh stimulation, tumor-associated 
stromal cells secrete soluble proteins that induce either pro-
liferation or differentiation of epithelial tumors. The net 
effect of proliferation and differentiation signals induced by 
Hh-responsive cells in the initiation and growth of epithelial 
tumors is currently under extensive investigation in various 
mouse models of human cancers. Consistent with the re-
quirement for Hh signaling in early development, roles of 
Hh signaling in the maintenance of adult stem cells/progen- 
itor cells have been gradually recognized in recent years. 
Intriguingly, the Hh response acts on stem/progenitor cells 
directly, such as neural precursors [11] and hematopoietic 
stem cells (HSCs) [12], although exact mechanisms of Hh 
signaling in HSC maintenance and regeneration are still 
unclear. Hh signaling can alternatively act in a paracrine 
manner to regulate stem cell homeostasis in a specific tissue. 
A recent study [3] employed mouse genetic approaches to 
reveal extensive crosstalk between Shh-expressing epitheli-
al cells with enriched stem cell units and Hh-responsive 
stromal cells in homeostasis and a bacterial injury-induced 
model of pathological regeneration of the bladder urotheli-
um. Despite progress in identifying either Hh-secreting or 
Hh-responding cells among the above-mentioned adult stem 
cells, the absolute proportions of adult stem cells that se-
crete Hh ligands or respond to Hh stimulation are largely 
unknown. Clear understanding of this aspect by co-staining 
or fluorescence-activated cell sorting (FACS) with stem cell 
markers would help to clarify the specific expression of Hh 
pathway components in adult stem cells.  
As a closely related signaling pathway that also plays 
critical roles in embryogenesis and adult tissue homeostasis, 
the Wnt signaling pathway has well-characterized activities 
in tissue-specific stem cells [13] and the development of 
various epidermal-derived tumors [14]. Intriguingly, com-
pared with the predominant model in which Hh-responsive 
stromal cells affect the growth of epithelial stem cells and 
epithelial tumor cells that secrete Hh ligands, the Wnt 
pathway response is frequently restricted in stem cells and 
epithelial tumor cells. In contrast to the epithelial-specific 
expression pattern of Wnt responsive cells, Wnt ligands can 
be expressed in either stromal cells or Wnt-responsive epi-
thelial cells. In the former, the Wnt pathway acts via a simi-
lar paracrine mechanism as the above-described Hh path-
way, except that Wnt pathway responses occur in epithelial 
cells and Wnt ligands are secreted from stromal cells. 
However, in the latter case, Wnt pathway activity acts 
cell-autonomously to regulate epithelial stem cell and can-
cer cell growth. Notably, compared with the three Hh lig-
ands (Shh, Ihh, and Dhh) in mammalian cells, the Wnt lig-
and family includes 19 Wnt proteins that execute their bio-
logical activities in tissue- and context-dependent manners 
[15]. A clear example of Wnt pathway activity in stem cell 
and tumor growth is its well-documented roles in the 
maintenance of mammary stem cells and carcinogenesis of 
mammary tumors. Recent studies [16,17] have employed 
FACS and lineage-labeling technologies to identify Wnt- 
responsive cells as a subset of mammary epithelial cells 
with enriched mammary regenerative units (MRU). Wnt 
signaling activity potentiates the MRU of mammary stem 
cells as evidenced by the activity of exogenous Wnt protein 
to clonally expand mammary stem cells in vitro and to 
maintain their ability to generate functional mammary 
glands in in vivo transplantation assays. Because a proper 
regulated level of Wnt signaling is critical to maintain the 
MRU of mammary epithelial cells, deregulated Wnt path-
way activity in mammary epithelial cells is frequently asso-
ciated with the development and growth of human breast 
cancer [18]. Importantly, genetic up-regulation of Wnt 
pathway activity in mouse mammary epithelial cells via 
mammary epithelial-specific drivers such as mouse mam-
mary tumor virus (MMTV) leads to the formation of mam-
mary adenocarcinoma [19] in a mouse model (MMTV-Wnt) 
of breast cancer. This finding highlights the critical 
cell-autonomous role of Wnt in breast cancer development.  
Although the above-mentioned epithelial Wnt and stro-
mal Hh responses contribute to epithelial-stromal interac-
tions in different cellular compartments, their activities are 
similarly required during embryonic development and adult 
tissue homeostasis. Thus, it is important to determine in a 
given tissue where epithelial Wnt and stromal Hh pathway 
activities are both active whether these pathway activities 
can reciprocally crosstalk with each other. Indeed, Wnt and 
Hh pathway activities negatively regulate each other in 
neural tube development [20]. Wnt is secreted from the 
ventral spinal cord and specifies ventral cell fates via its 
antagonistic activity that represses dorsally restricted Hh 
pathway activity. Conversely, a Hh response is initiated in 
the floor plate of the neural tube and determines dorsal cell 
fates via its antagonistic activity that represses Wnt activity. 
Intriguingly, a recent study [3] describes unexpected posi-
tive crosstalk of Hh and Wnt pathways in the adult urothe-
lium. Shh is secreted from basal cells of the bladder urothe-
lium, which up-regulates Wnt and Fgf ligand secretion in 
Shh-responsive stromal cells, while secreted Wnt ligands 
reciprocally promote the growth of urothelial epithelium 
(Figure 1). Importantly, this circuit of Wnt-Hh crosstalk is 
required for regenerative activity of the bladder urothelium 
in response to bacterial injury because genetic or pharma-
cological interventions of this Wnt-Hh crosstalk delay such 
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regenerative proliferation. It would be interesting to exam-
ine the significance of this type of positive interaction be-
tween Wnt and Hh signaling in the initiation and mainte-
nance of bladder tumors. Furthermore, it would be useful to 
determine whether this type of Wnt-Hh crosstalk occurs   
in other epithelial-stromal interactions that similarly involve 
epithelial Wnt responses and stromal Hh responses    
(Figure 1). 
Because paracrine activities of Hh and Wnt are required 
for stem cell maintenance and epithelial tumor growth, 
pharmacological activation or inhibition of these pathways 
would have therapeutic value for diseases driven by dereg-
ulated activities of Wnt or Hh pathways. Both Hh and Wnt 
pathway activities are initiated by G protein-coupled recep-
tor (GPCR)-like membrane receptors/co-receptors that can 
be targeted easily by drugs. Therefore, extensive efforts 
have been made to identify Hh and Wnt pathway-specific 
antagonists in small molecule libraries. As a result of high 
throughput analyses, non-toxic anti-Hh drug candidates are 
currently being tested in over 40 clinical trials sponsored by 
six major pharmaceutical companies for the treatment of 
brain, skin, and visceral cancers including medulloblastoma, 
BCC, pancreatic adenocarcinoma, and lung cancer. The 
most advanced anti-Hh drug candidate, Vismodegib, from 
Genentech was approved by the Food and Drug Admin-
istration on 2012 [21]. Compared with Hh pathway antago-
nists that mainly target membrane GPCR-like receptor in 
the Hh pathway, approaches to manipulate the Wnt pathway 
range from targeting critical regulators of Wnt secretion to 
essential mediators of the Wnt response [22]. The activities 
of these Wnt pathway modulators in various diseases are 
currently under investigation by major pharmaceutical 
companies. Considering the diversity of Wnt ligands and 
models in which the Wnt pathway can be operated in either 
paracrine or autocrine manners, the efficacy of these Wnt 
pathway modulators may have to be evaluated in a con-
text-dependent manner.  
Accumulating data have revealed that tumor epithelial 
cells are consistently exposed to and require growth signals 
from tumor-associated stromal cells. Such findings un-
doubtedly suggest an alternative strategy to inhibit tumor 
growth by interruption of the epithelial-stromal interactions 
required for tumor growth. Identification of Hh and Wnt 
pathway crosstalk as an essential regulatory mechanism in 
epithelial-stromal interactions will shed light on the devel-




Figure 1  According to a recent study [3], Shh is secreted from basal cells of the bladder urothelium and Hh-responsive cells in the surrounding stroma 
secrete soluble factors, such as Fgf and Wnt family proteins, which can feedback to promote bladder urothelial proliferation. This crosstalk acts to protect the 
bladder from bacterial injury-induced degeneration. However, the exact role remains to be determined for this Hh-Wnt crosstalk circuit in the initiation and 
maintenance of bladder tumors. 
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time is clearly ahead as Hh-Wnt crosstalk is implicated in 
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